Voyager Acquisition Corp. (VACH)

US — Financial Services Sector
Peers:

Automate Your Wheel Strategy on VACH

With Tiblio's Option Bot, you can configure your own wheel strategy including VACH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol VACH
  • Rev/Share 0.0
  • Book/Share 9.8878
  • PB -22.6023
  • Debt/Equity 0.0
  • CurrentRatio 5.8145
  • ROIC -0.0035

 

  • MktCap 328583729.0
  • FreeCF/Share -0.0366
  • PFCF -354.7421
  • PE 39.6687
  • Debt/Assets 0.0
  • DivYield 0
  • ROE 0.0551

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
VACH
Published: May 29, 2025 by: GlobeNewsWire
Sentiment: Neutral

VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors

Read More
image for news VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
VACH
Published: May 29, 2025 by: GlobeNewsWire
Sentiment: Neutral

VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors

Read More
image for news VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
VACH
Published: May 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC™ Antibody Formats Towards Clinical Studies Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC™ Antibody Formats Towards Clinical Studies

Read More
image for news VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

About Voyager Acquisition Corp. (VACH)

  • IPO Date 2024-09-30
  • Website https://www.voyageracq.com
  • Industry Shell Companies
  • CEO Adeel Rouf Ennis
  • Employees None
Voyager Acquisition Corp. is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination. The company has not selected any specific business combination target and has not initiated any substantive discussions with potential targets.